Oxford Cannabinoid Technologies Holdings Plc confirmed the appointment of Clarissa Sowemimo-Coker as permanent CEO, effective immediately. Clarissa has been with the Company for over four years and was appointed interim CEO in December 2022. Since then, she has successfully led the Company to its first submission to the UK Medicines and Healthcare Products Regulatory Agency and the Wales Research Ethics Committee 2, whilst continuing to build stronger relationships with external stakeholders.
Oxford Cannabinoid Technologies Holdings Plc
Equities
OCTP
GB00BMVMRB86
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.186 GBX | +3.33% | +20.00% | -70.24% |
17/05 | Oxford Cannabinoid says it remains bound by Takeover Code | AN |
08/05 | Oxford Cannabinoid shares plummet following delisting request | AN |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-70.24% | 2.49M | |
+64.92% | 62.59B | |
-1.85% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.05% | 26.21B | |
-21.96% | 19.09B | |
+4.21% | 13.08B | |
+25.74% | 12.26B | |
+27.42% | 12.05B |
- Stock Market
- Equities
- OCTP Stock
- News Oxford Cannabinoid Technologies Holdings Plc
- Oxford Cannabinoid Technologies Holdings plc Appoints Clarissa Sowemimo-Coker as Permanent CEO